tirzepatide vs semaglutide head to head vs. Semaglutide: What the Head-to-Head Trial Showed — Shreveport Direct Care Tirzepatide vs. semaglutide: Study compares

Choosing an unlicensed product often means there is no traceability, making it difficult for medical professionals to manage complications if they arise

WeghuberDBarrettTBarrientos-PrezMGiesIHesseDJeppesenOKet alOnce-weekly semaglutide in adolescents with obesity

Make sure your choice offers robust insurance and prior authorization help, as Klinic does, removing hurdles many clinics leave patients to face on their own

Valid reasons include: Inadequate weight loss on Wegovy despite 6+ months at 2.4 mg Insurance coverage change (Zepbound covered, Wegovy not) Persistent side effects on semaglutide that may improve with tirzepatide's different receptor profile Patient preference for potentially greater weight loss Invalid or questionable reasons: Switching after only 8 to 12 weeks on Wegovy (insufficient time to assess response) Switching due to transient nausea during titration (both medications cause nausea) Switching based on anecdotal reports without clinical rationale Step 2: Choose washout vs overlap strategy